Cargando…
(6) BNT162b2-Vaccine-Induced Neutralization Responses are Immune Correlates of Clinical Protection Against SARS-CoV-2 in Heart Transplant Recipients
PURPOSE: Heart transplant (HT) recipients are at high risk for poor immunity after COVID-19 vaccination. A multidose vaccine strategy is thus recommended, but the clinical outcomes and immune correlates of clinical protection against SARS-CoV-2 are unknown. METHODS: In a case-control study of HT rec...
Autores principales: | Peled, Y., Patel, J., Raanani, E., Segev, A., Matezki, S., Ram, E., Fardman, A., Beigel, R., Atari, N., Kliker, L., Elkader, B. Abd, Mandelboim, M., Afek, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068071/ http://dx.doi.org/10.1016/j.healun.2023.02.022 |
Ejemplares similares
-
(7) Cellular and Humoral Responses to Vaccination Before or after SARS-CoV-2 Infection - Bridging the Knowledge Gap to End the Pandemic for Heart Transplant Recipients
por: Peled, Y., et al.
Publicado: (2023) -
(8) 5th Dose Bivalent Omicron-Containing Booster Vaccine Against Covid-19 in Heart Transplant Recipients
por: Peled, Y., et al.
Publicado: (2023) -
Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients
por: Peled, Yael, et al.
Publicado: (2023) -
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variant
por: Peled, Yael, et al.
Publicado: (2022) -
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience
por: Peled, Yael, et al.
Publicado: (2022)